Rachel Knevel
, Saskia le Cessie
, Chikashi C. Terao
, Kamil Slowikowski
, Jing Cui, Tom W. J. Huizinga
, Karen H. Costenbader, Katherine P. Liao
, Elizabeth W. Karlson, Soumya Raychaudhuri
Abstract
A genetic risk tool could be used at the first clinical visit of patients with inflammatory arthritis to increase diagnostic efficacy.
Reply by Email